Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Stryker Corp. | 17 | 0 | 4 | 0 | €313.60 | €331.52 | 5.716% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €61.30 | €80.00 | 30.506% |
| Geron Corp. | 10 | 0 | 2 | 0 | €3.54 | €4.59 | 29.867% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €58.50 | €75.80 | 29.573% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.30 | €247.61 | 16.631% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €187.75 | - | - |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.32 | €2.78 | 110.879% |
| Cutera Inc. | 1 | 0 | 0 | 0 | €1.99 | €3.00 | 51.057% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €13.96 | - | - |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.00 | €26.58 | 10.756% |
| Corcept Therapeutics Inc. | 9 | 0 | 2 | 0 | €21.32 | €33.55 | 57.348% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €127.05 | €137.63 | 8.331% |
| Community Health Systems Inc. | 4 | 3 | 1 | 0 | €3.04 | €5.36 | 76.461% |
| Lemaitre Vascular Inc | 1 | 0 | 0 | 0 | €59.00 | - | - |
| ShockWave Medical Inc | 1 | 0 | 0 | 0 | €306.80 | - | - |
| X4 Pharmaceuticals, Inc. | 5 | 0 | 2 | 0 | €1.09 | €2.76 | 153.003% |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| Immunogen Inc. | 6 | 0 | 0 | 0 | €28.97 | - | - |
| Insmed Inc. | 13 | 1 | 3 | 1 | €23.20 | €44.01 | 89.684% |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.02 | €13.74 | 1243.324% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.44 | €8.50 | 32.090% |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €91.00 | €95.79 | 5.269% |